Hybrid chromophobe renal cell neoplasm

被引:54
作者
Mai, KT
Dhamanaskar, P
Belanger, E
Stinson, WA
机构
[1] Ottawa Hosp, Dept Lab Med, Div Anatom Pathol, Ottawa, ON K1Y 4E9, Canada
[2] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON, Canada
关键词
D O I
10.1016/j.prp.2005.03.008
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Hybrid renal cell neoplasms (HRCNs) containing areas of tumor cells displaying cytological features of chromophobe renal cell carcinoma (CHRCC) and renal oncocytoma (RO) have been recently described in patients with renal oncocytosis and Birt-Hogg-Dube (BHD) syndrome (autosomal dominant genodermatosis). In this study, we identified cases of sporadic HRCN. We reviewed 425 consecutive renal cell carcinomas (RCC), 18 CHRCC, six HRCN, and 25 RO. Five HRCN were identified, including four from the group of RCC and two from RO. Patient age ranged from 40 to 68 years (mean age: 54 years), and the male:female ratio was 4:1. Tumors measured from 1. 8 to 5 cm (mean diameter: 3.0cm). Tumoral necrosis was not seen. Vascular invasion into medium-sized veins was identified in one HRCN. Chromophobe cells accounted for 20-80% of the tumors. Hale's colloidal stain showed weak to moderate diffuse cytoplasmic staining in scattered cells corresponding to those displaying routine staining features of chromophobe cells. Areas of oncocytic cells in studied tumors and control oncocytomas showed negative or focal cytoplasmic staining usually bordering extra- or intra-cytoplasmic lumina. Immunostaining for cytokeratin 7 and vimentin showed focal immunoreactivity in three cases and negative reactivity in all six cases, respectively. None of the study cases had microscopic RO, as commonly seen in renal oncocytosis, or were associated with BHD syndrome Sporadic HRCN accounted for 1% of RCC. They were of smaller size than RCC and were associated with a favorable prognosis. (c) 2005 Elsevier GmbH. All rights reserved.
引用
收藏
页码:385 / 389
页数:5
相关论文
共 30 条
[1]  
Bugert P, 1997, LAB INVEST, V76, P203
[2]   Renal oncocytosis presenting in childhood: A case report [J].
Chen, TS ;
McNally, M ;
Hulbert, W ;
di Sant'Agnese, PA ;
Huang, JT .
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2003, 11 (04) :325-329
[3]  
CochandPriollet B, 1997, ARCH PATHOL LAB MED, V121, P1081
[4]   CYTOGENETIC ANALYSIS OF 6 RENAL ONCOCYTOMAS AND A CHROMOPHOBE CELL RENAL-CARCINOMA - EVIDENCE THAT-Y,-1 MAY BE A CHARACTERISTIC ANOMALY IN RENAL ONCOCYTOMAS [J].
CROTTY, TB ;
LAWRENCE, KM ;
MOERTEL, CA ;
BARTELT, DH ;
BATTS, KP ;
DEWALD, GW ;
FARROW, GM ;
JENKINS, RB .
CANCER GENETICS AND CYTOGENETICS, 1992, 61 (01) :61-66
[5]  
Dijkhuizen T, 1997, INT J CANCER, V73, P521, DOI 10.1002/(SICI)1097-0215(19971114)73:4<521::AID-IJC11>3.0.CO
[6]  
2-C
[7]  
GERHARZ CD, 1993, AM J PATHOL, V142, P81
[8]   LOW CHROMOSOME-NUMBER IN CHROMOPHOBE RENAL-CELL CARCINOMAS [J].
KOVACS, A ;
KOVACS, G .
GENES CHROMOSOMES & CANCER, 1992, 4 (03) :267-268
[9]   MOLECULAR CYTOGENETICS OF RENAL-CELL TUMORS [J].
KOVACS, G .
ADVANCES IN CANCER RESEARCH, VOL 62, 1993, 62 :89-124
[10]   Utility of cytokeratin 7 for distinguishing chromophobe renal cell carcinoma from renal oncocytoma [J].
Leroy, X ;
Moukassa, D ;
Copin, MC ;
Saint, F ;
Mazeman, E ;
Gosselin, B .
EUROPEAN UROLOGY, 2000, 37 (04) :484-487